1. Home
  2. VERU vs AERT Comparison

VERU vs AERT Comparison

Compare VERU & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • AERT
  • Stock Information
  • Founded
  • VERU 1971
  • AERT 2012
  • Country
  • VERU United States
  • AERT Singapore
  • Employees
  • VERU N/A
  • AERT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • AERT Professional Services
  • Sector
  • VERU Health Care
  • AERT Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • AERT Nasdaq
  • Market Cap
  • VERU 107.2M
  • AERT 99.7M
  • IPO Year
  • VERU 1990
  • AERT N/A
  • Fundamental
  • Price
  • VERU $0.58
  • AERT $1.06
  • Analyst Decision
  • VERU Strong Buy
  • AERT
  • Analyst Count
  • VERU 4
  • AERT 0
  • Target Price
  • VERU $4.00
  • AERT N/A
  • AVG Volume (30 Days)
  • VERU 996.7K
  • AERT 55.3K
  • Earning Date
  • VERU 12-06-2024
  • AERT 11-26-2024
  • Dividend Yield
  • VERU N/A
  • AERT N/A
  • EPS Growth
  • VERU N/A
  • AERT N/A
  • EPS
  • VERU N/A
  • AERT N/A
  • Revenue
  • VERU $14,091,909.00
  • AERT $72,846,000.00
  • Revenue This Year
  • VERU N/A
  • AERT N/A
  • Revenue Next Year
  • VERU N/A
  • AERT N/A
  • P/E Ratio
  • VERU N/A
  • AERT N/A
  • Revenue Growth
  • VERU N/A
  • AERT 28.04
  • 52 Week Low
  • VERU $0.36
  • AERT $1.00
  • 52 Week High
  • VERU $1.92
  • AERT $3.12
  • Technical
  • Relative Strength Index (RSI)
  • VERU 24.06
  • AERT 19.59
  • Support Level
  • VERU $0.72
  • AERT $1.18
  • Resistance Level
  • VERU $0.83
  • AERT $1.75
  • Average True Range (ATR)
  • VERU 0.06
  • AERT 0.20
  • MACD
  • VERU -0.02
  • AERT -0.04
  • Stochastic Oscillator
  • VERU 1.38
  • AERT 6.49

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: